<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2016.5169</article-id>
<article-id pub-id-type="publisher-id">mmr-13-06-5207</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Changes in mesenchymal stem cells following long-term culture <italic>in vitro</italic></article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>GU</surname><given-names>YAJUN</given-names></name><xref rid="af1-mmr-13-06-5207" ref-type="aff">1</xref><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref><xref rid="fn1-mmr-13-06-5207" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>LI</surname><given-names>TAO</given-names></name><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref><xref rid="fn1-mmr-13-06-5207" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>DING</surname><given-names>YANLING</given-names></name><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>SUN</surname><given-names>LINGXIAN</given-names></name><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>TU</surname><given-names>TAO</given-names></name><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHU</surname><given-names>WEI</given-names></name><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>HU</surname><given-names>JIABO</given-names></name><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>SUN</surname><given-names>XIAOCHUN</given-names></name><xref rid="af2-mmr-13-06-5207" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-mmr-13-06-5207"/></contrib></contrib-group>
<aff id="af1-mmr-13-06-5207">
<label>1</label>The Blood Bank of Jiangyin, Wuxi, Jiangsu 214400, P.R. China</aff>
<aff id="af2-mmr-13-06-5207">
<label>2</label>School of Medical Science and Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-13-06-5207">Correspondence to: Professor Xiaochun Sun, School of Medical Science and Laboratory Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013, P.R. China, E-mail: <email>xiaochun@ujs.edu.cn</email></corresp><fn id="fn1-mmr-13-06-5207">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>06</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>04</month>
<year>2016</year></pub-date>
<volume>13</volume>
<issue>6</issue>
<fpage>5207</fpage>
<lpage>5215</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>05</month>
<year>2015</year></date>
<date date-type="accepted">
<day>22</day>
<month>02</month>
<year>2016</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016, Spandidos Publications</copyright-statement>
<copyright-year>2016</copyright-year></permissions>
<abstract>
<p>Mesenchymal stem cells (MSCs), which can be isolated from umbilical cords and induced to differentiate into multiple cell types <italic>in vitro</italic>, represent an ideal source for cell and gene therapy. MSCs are typically expanded in culture prior to their therapeutic application. However, similar to other types of stem cell, MSCs undergo senescence following a certain number of cell expansion passages <italic>in vitro</italic>, and eventually stop proliferating. The objective of the present study was to measure the changes that occur over successive passages of MSCs during long-term <italic>in vitro</italic> culture, and to detect the effect of aging on MSC morphology, phenotype, proliferation, cell cycle, differentiation, intracellular reactive oxygen species (ROS) levels and gene expression. To understand the importance of oxidative stress in the aging of adult stem cells, the current study established a cell model of H<sub>2</sub>O<sub>2</sub>-induced MSC premature senescence. Analysis of the biological characteristics of human umbilical cord MSCs during replicative and premature senescence revealed the importance of extrinsic factors in the aging of stem cells, particularly ROS. The findings of the present study suggest that cellular senescence, a state of irreversible growth arrest, can be triggered by ROS. Thus, it is important to improve the extrinsic culture environment of MSCs to retain the phenotype of expanded cells and delay the process of senescence prior to their clinical application.</p></abstract>
<kwd-group>
<kwd>mesenchymal stem cells</kwd>
<kwd>senescence</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>premature senescence</kwd>
<kwd>H<sub>2</sub>O<sub>2</sub></kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Mesenchymal stem cells (MSCs) are a promising cell source for use in tissue regeneration and their potential therapeutic application has already been investigated in several clinical trials (<xref rid="b1-mmr-13-06-5207" ref-type="bibr">1</xref>&#x02013;<xref rid="b3-mmr-13-06-5207" ref-type="bibr">3</xref>). Human MSCs have the ability to differentiate into different mesodermal cell lineages, including osteocytes, chondrocytes, adipocytes, hepatocytes and neurons (<xref rid="b4-mmr-13-06-5207" ref-type="bibr">4</xref>,<xref rid="b5-mmr-13-06-5207" ref-type="bibr">5</xref>). Therefore, MSCs have important therapeutic potential. Typically, these cells are expanded prior to their clinical application. However, MSCs have a limited lifespan <italic>in vitro</italic>, as do any normal somatic cells, and there is no precise molecular definition of MSC long-term culture <italic>in vitro</italic>. Several studies have demonstrated that long-term culture of MSCs results in continuous changes to the cells, including decreased proliferation rate, increased cell size and different differentiation potentials (<xref rid="b6-mmr-13-06-5207" ref-type="bibr">6</xref>,<xref rid="b7-mmr-13-06-5207" ref-type="bibr">7</xref>). These problems have hindered the expansion of MSCs for therapeutic use, causing a major bottleneck in clinical applications. MSCs have become an attractive therapeutic tool due of their unique characteristics, including their ability to self-renewal, and ease of isolation and expansion. MSCs possess a broad spectrum for regenerative medicine due to their potential to repair tissue and to differentiate into osteoblasts, chondroblasts, adipocytes and myoblasts. The transplantation of pluripotent MSCs has been tested in the treatment of neurological disorders, such as Parkinson's disease, cerebral infarction, brain injury and spinal cord injury, bone tissue engineering, cardiovascular diseases, severe liver damage repair, pulmonary fibrosis and reduction of bone marrow transplant rejection indicating the potential for porting applications.</p>
<p>It has been reported that long-term culture of MSCs causes the cells to undergo replicative senescence with the cell morphology becoming enlarged and flattened, the development of prominent nucleoli and cytoplasmic granules, alteration in the differentiation potential, and shortened telomere length over progressively increasing passages (<xref rid="b8-mmr-13-06-5207" ref-type="bibr">8</xref>). Additionally, these senescent cells can be stained by senescence-associated &#x003B2;-galactosidase (SA-&#x003B2;-gal). It is important, therefore, to fully understand the biological alterations that occur in these expanded stem cell populations.</p>
<p>Cellular senescence is induced by intrinsic and extrinsic factors (<xref rid="b9-mmr-13-06-5207" ref-type="bibr">9</xref>,<xref rid="b10-mmr-13-06-5207" ref-type="bibr">10</xref>). With numerous passages, cell senescence can be triggered by replicative exhaustion, DNA damage and telomere shortening. Increasing evidence indicates that the continuous accumulation of intracellular reactive oxygen species (ROS) is a major initiating factor of replicative senescence (<xref rid="b11-mmr-13-06-5207" ref-type="bibr">11</xref>,<xref rid="b12-mmr-13-06-5207" ref-type="bibr">12</xref>). Furthermore, extrinsic stresses, such as oxidative stress, may affect intrinsic factors, and subsequently lead to DNA damage accumulation and telomere shortening. In addition to replicative senescence, premature senescence is another model of <italic>in vitro</italic> senescence. Premature senescence is induced by various extrinsic factors, including hydrogen peroxide, ionizing radiation, high glucose, D-galactose, high oxygen and old rat serum (<xref rid="b13-mmr-13-06-5207" ref-type="bibr">13</xref>&#x02013;<xref rid="b15-mmr-13-06-5207" ref-type="bibr">15</xref>). In addition, human fibroblasts undergo premature senescence when cultured in 8-methoxypsoralen/ultraviolet A conditions (<xref rid="b16-mmr-13-06-5207" ref-type="bibr">16</xref>). Zhang <italic>et al</italic> (<xref rid="b14-mmr-13-06-5207" ref-type="bibr">14</xref>) reported that old rat serum induced the senescence of adult MSCs, and inhibited their proliferation and survival. Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a redox factor for transcription factors that alters trinucleotide stores, which are vital to energy metabolism, via regulation of DNA repair processes and transcription factors, including P53 (<xref rid="b17-mmr-13-06-5207" ref-type="bibr">17</xref>). P21, a cyclin-dependent kinase inhibitor, is a major transcriptional target of P53. It was originally identified as a gene that inhibits DNA synthesis and promotes cell cycle arrest (<xref rid="b18-mmr-13-06-5207" ref-type="bibr">18</xref>). Further analysis demonstrated that senescence of numerous cell lines was correlated with the upregulation of P21 and P53 (<xref rid="b19-mmr-13-06-5207" ref-type="bibr">19</xref>). Thus, establishing an optimized microenvironment for the culture and expansion of MSCs that preserves their properties and prolongs their lifespan is imperative (<xref rid="b20-mmr-13-06-5207" ref-type="bibr">20</xref>&#x02013;<xref rid="b23-mmr-13-06-5207" ref-type="bibr">23</xref>).</p>
<p>Cellular senescence is a complex process and the sequence of its molecular mechanisms is thus far unknown. Sharpless and DePinho (<xref rid="b24-mmr-13-06-5207" ref-type="bibr">24</xref>) proposed that humans grow old due to stem cell aging as a result of mechanisms designed to suppress the development of cancer. Thus, it may be important to determine how individuals grow old and how cancer develops via investigation of the process of stem cell aging. The current study compares several biological characteristics of human umbilical cord MSCs (hucMSCs) during long-term <italic>in vitro</italic> expansion for passages 4, 11 and 17 (P4, P11 and P17). In addition, the present study established an H<sub>2</sub>O<sub>2</sub>-induced premature senescence model to examine MSC senescence.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Isolation and culture of hucMSCs</title>
<p>The experimental protocol was approved by Jiangsu University ethics committee (Zhenjiang, China). Fresh umbilical cords were collected in March 2015, immediately after birth from healthy donors at the First People's Hospital of Zhenjiang (Zhenjiang, China). The umbilical cords were rinsed twice in phosphate-buffered saline (PBS) until the cord blood was cleared. The blood vessels were removed from each cord, then the remaining tissue was cut into 1-mm<sup>3</sup> pieces, and suspended in low-glucose Dulbecco's modified Eagle's medium (L-DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal bovine serum (FBS; Thermo Fisher Scientific, Inc.), 1% penicillin and 1% streptomycin (Beyotime Institute of Biotechnology, Haimen, China). All cultures were incubated at 37<italic>&#x000B0;</italic>C with an atmosphere of 5% CO<sub>2</sub> in a humidified chamber. The medium was changed every 3 days after initial plating. When well-developed colonies of fibroblast-like cells reached 70-80% confluence, the cells were trypsinized with 0.25% trypsin-EDTA (Thermo Fisher Scientific, Inc.) and passaged into new culture flasks for further expansion. To establish a cell model of H<sub>2</sub>O<sub>2</sub>-induced MSC premature senescence, early passage (P4) hucMSCs were treated with H<sub>2</sub>O<sub>2</sub> at different concentrations (0, 200, 400, 600 and 800 <italic>&#x003BC;</italic>M) for 2 h. The stimulus was then removed and cells were further incubated in fresh medium for 48 h.</p></sec>
<sec>
<title>Flow cytometry</title>
<p>To determine the phenotypes of hucMSCs, fluo-rescein isothiocyanate (FITC)- or phycoerythrin (PE)-labeled mouse monoclonal antibodies against human leukocyte antigen (HLA)-DR, cluster of differentiation (CD)105, CD34, CD29, CD90 and CD44 (1:10; BD Biosciences, Franklin Lakes, NJ, USA; cat. nos. 555811, 560839, 348053, 555443, 555596 and 555479, respectively) were used. Briefly, at P4, MSCs were trypsinized, washed twice with PBS and stained with the monoclonal antibodies, according to the manufacturer's protocol. Mouse monoclonal PE-immunoglobulin G1 (IgG1) and FITC-IgG1 (BD Biosciences; cat. nos. 555574 and 555573, respectively) were used as isotype controls. The stained cells were analyzed using the FACSAria flow cytometer(BD Biosciences).</p></sec>
<sec>
<title>Morphological observation of hucMSCs</title>
<p>The cell surface morphology of hucMSCs was analyzed using scanning electron microscopy (SEM; Hitachi S-3400N; Hitachi, Ltd., Tokyo, Japan) at P4, P11 and P17. Cells were seeded in 6-well plates and the media was removed following 3 days of culture. The cells were washed with PBS and fixed with 2.5% glutaraldehyde (Sangon Biotech Co., Ltd., Shanghai, China) for 1 h. The cells were then rinsed with distilled water and dehydrated with a series of ethanol gradients starting at 30% and increasing to 50, 70, 80, 90, 95 and 100% (v/v). Subsequently, the cells were air-dried overnight at room temperature in a fume hood. The cells were gold-coated and cell morphology was analyzed using SEM.</p>
<p>To image the cell nuclei, cells were cultured at a comparable density on coverslips in 6-well plates. They were washed with PBS, fixed for 15 min with 4% formaldehyde (Sangon Biotech Co., Ltd.) and washed with PBS 3 times. DNA was visualized with 4&#x02032;6-diamidino-2-phenylindole (1 mg/ml) (Beyotime Institute of Biotechnology) by fluorescence microscopy (Molecular Devices, LLC, Sunnyvale, CA, USA).</p></sec>
<sec>
<title>Cell proliferation assay</title>
<p>Assessment of the proliferative ability of hucMSCs was performed using a 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT; AMRESCO LLC, Solon, OH, USA) assay at P4, P11 and P17. The cells were seeded in 96-well plates at a density of 1,000 cells per well. At days 1, 2, 3, 4, 5, 6 and 7, MTT (20 <italic>&#x003BC;</italic>l) was added to each well for 4 h. When the reaction was terminated, the medium was discarded and 150 <italic>&#x003BC;</italic>l dimethylsulfoxide (Sigma-Aldrich, St. Louis, MO, USA) was added to each well. Following uniform oscillation for 10 min to fully dissolve the purple formazan crystals, the absorbance values were determined at 490 nm with a spectrophotometer (FLX800; BioTek Instruments, Inc., Winooski, VT, USA).</p></sec>
<sec>
<title>SA-&#x003B2;-gal staining</title>
<p>SA-&#x003B2;-gal activity was analyzed in different passages (P4, P11 and P17) of hucMSCs using a SA-&#x003B2;-gal staining kit (Beyotime Institute of Biotechnology), according to the manufacturer's protocol. In brief, the cells were cultured to comparable densities on coverslips in 24-well plates and washed with PBS, fixed for 15 min with 4% formaldehyde and washed with PBS. Subsequently, the cells were incubated overnight at 37<italic>&#x000B0;</italic>C in a CO<sub>2</sub>-free chamber with freshly prepared SA-&#x003B2;-gal stain solution. SA-&#x003B2;-gal-positive cells exhibited a blue color; the number of positive cells was counted for every 200 cells in randomly selected fields of view using light microscopy (TE300; Nikon Corporation, Tokyo, Japan).</p></sec>
<sec>
<title>Cell cycle analysis</title>
<p>Cells at P4, P11 and P17 were collected, washed twice with PBS and stained with propidium iodide (Sigma-Aldrich) for 30 min in dark conditions. The stained cells were analyzed by flow cytometry (FACSAria; BD Biosciences).</p></sec>
<sec>
<title>Generation of conditioned media (CM) for hucMSC migration assay</title>
<p>To prepare CM, 8&#x000D7;0<sup>4</sup> hucMSCs of P4, P11 and P17 were plated on 6-well culture plates with 10% FBS L-DMEM and allowed to adhere overnight at 37<italic>&#x000B0;</italic>C with 5% CO<sub>2</sub> atmosphere. The following day, the media was removed, the cells were washed twice with PBS and then re-incubated with 1.5 ml serum-free culture media. After 12 h, the CM was collected, centrifuged for 5 min at 447 &#x000D7; g to remove cell debris and passed through a 0.45-<italic>&#x003BC;</italic>m filter (Sigma-Aldrich). CM aliquots were frozen at -20<italic>&#x000B0;</italic>C until analysis (not exceeding 2 weeks).</p>
<p>P4 MSCs (4&#x000D7;10<sup>4</sup>) in 200 <italic>&#x003BC;</italic>l serum-free L-DMEM were plated in the upper chambers and 600 <italic>&#x003BC;</italic>l undiluted CM with 10% FBS was added to the lower chambers. After 10 h of incubation, the cells were fixed with 4% formaldehyde for 30 min. The cells that remained on the membrane of the upper chamber were removed with cotton swabs and migrating cells were stained with crystal violet (Sigma-Aldrich). Four low-power fields (&#x000D7;100) were randomly selected in each chamber to observe the cells and the number of stained migrated cells on each image was counted.</p></sec>
<sec>
<title>ROS detection</title>
<p>To detect the accumulation of intracellular ROS in hucMSCs, a ROS assay kit (Beyotime Institute of Biotechnology) was used. Following culture to different passages (P4, P11 and P17), the cells were washed 3 times in serum-free medium and incubated in a final concentration of 10 mM dihydrodichlorofluorescein diacetate (H2DCFDA) at 37<italic>&#x000B0;</italic>C for 25 min. The media was then removed and cells were washed 3 times with serum-free medium. The cells were observed using a fluorescence microscope (TE300; Nikon Corporation).</p>
<p>To quantify the ROS level, the H2DCFDA fluorescence intensity of the cells was detected by flow cytometry. Briefly, 5&#x000D7;10<sup>4</sup> cells were collected and resuspended in a final concentration of 10 mM H2DCFDA with serum-free medium. After 25 min incubation at 37<italic>&#x000B0;</italic>C, cells were washed with serum-free medium 3 times and resuspended in PBS, then placed on ice for immediate detection using a FACScan flow cytometer (BD Biosciences) with excitation at 488 nm and emission at 525 nm.</p></sec>
<sec>
<title>HucMSC differentiation assays</title>
<p>HucMSCs at P4, P11 and P17 were cultured in a medium containing either osteogenic (50 mM ascorbate-phosphate, 10 mM &#x003B2;-glycerophosphate and 0.1 mM dexamethasone) or adipogenic (1 mM dexamethasone, 10 mM insulin, 0.5 mM isobutyl-methylxanthine and 200 mM indomethacin) reagents (Sigma-Aldrich) at 5% CO<sub>2</sub> at 37<italic>&#x000B0;</italic>. After 2 weeks of culturing, osteogenic differentiation was assessed by the examination of neutrophil alkaline phosphatase with Alizarin Red dye (Sigma-Aldrich). After 3 weeks of culturing, adipogenic differentiation was detected via intracellular lipid vesicles; the cells were stained with Oil Red-O (Cyagen, Guangzhou, China) to detect lipids using an inverted microscope (TE300; Nikon Corporation).</p></sec>
<sec>
<title>Reverse transcription-polymerase chain reaction (RT-PCR)</title>
<p>Total RNA was isolated using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's instructions. Reverse transcription was conducted using Moloney murine leukemia virus reverse transcriptase (Promega, USA) and the obtained cDNA was subjected to PCR. PCR was performed using 1 <italic>&#x003BC;</italic>g of cDNA sample with 0.3 U of Taq polymerase (CinnaGen Co., Tehran, Iran), 200 <italic>&#x003BC;</italic>M dNTPs, 10 pM of each primer, reaction buffer and MgCl2 (Takara Bio, Inc., Otsu, Japan) in a 25-<italic>&#x003BC;</italic>l volume. PCR amplification was performed for 35 cycles using an ABI 2720 thermal cycler (Applied Biosystems; Thermo Fisher Scientific, Inc.). The cycling conditions were: 94<italic>&#x000B0;</italic>C for 30 sec, 60<italic>&#x000B0;</italic>C (primer) for 30 sec, 72<italic>&#x000B0;</italic>C for 30 sec and a final extension at 72<italic>&#x000B0;</italic>C for 10 min. The PCR products were separated on a 1.5% agarose gel, stained with ethidium bromide (Thermo Fisher Scientific, Inc.) and visualized under UV light using the GeneGenius bio-imaging system (Syngene, MD, USA). Primers were as follows: APE1/Ref-1, F 5&#x02032;-GCTTCGAGCCTG GATTAAGA-3&#x02032; and R 5&#x02032;-TCATCGCCTATGCCGTAAGA-3&#x02032;; P21, F 5&#x02032;-CTACCTCAGGCAGCTCAAG-3&#x02032; and R, 5&#x02032;-AGCCTCTACTGCCACCATC-3&#x02032;; P53, F 5&#x02032;-TCTGTGACTTGCACGTACTC-3&#x02032; and R 5&#x02032;-TGTAGTGGATGGTGGTACAG-3&#x02032;; &#x003B2;-actin, F 5&#x02032;-CACGAAACTACCTTCAACTC-3&#x02032; and R 5&#x02032;-CATACTCCTGCTTGCTGATC-3&#x02032;. The primers were produced by Shanghai Bio-Engineering Company (Shanghai, China).</p></sec>
<sec>
<title>Statistical analysis</title>
<p>All data are expressed as the mean &#x000B1; standard deviation. Statistical analysis was performed using GraphPad Prism software (version 5; GraphPad Software, Inc., La Jolla, CA, USA). All experiments were replicated 3 times. Analysis of variance was used to analyze variance among all groups, and Student's t-test was performed to compare experimental and relative control groups. P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Morphology and cell surface characteristics of hucMSCs in primary culture</title>
<p>Following the initial 7 days of primary culture, hucMSCs adhered to the plastic surface of the culture flasks and presented as a small population of single cells with spindle-like shape. On day 10 after initial plating, the cells exhibited long spindle-shaped fibroblastic cells, they had began to form colonies and were confluent (<xref rid="f1-mmr-13-06-5207" ref-type="fig">Fig. 1A</xref>). At P4, hucMSCs were positively stained with CD29, CD90, CD44 and CD105, but were negative for the hematopoietic lineage markers CD34 and HLA-DR, as measured by fluorescence-activated cell sorting (FACS) analysis (<xref rid="f1-mmr-13-06-5207" ref-type="fig">Fig. 1B</xref>).</p></sec>
<sec>
<title>Changes in hucMSCs during long-term in vitro culture</title>
<p>HucMSCs from the same donors were characterized by their morphology, growth, SA-&#x003B2;-gal activity and differentiation capacity. The present study observed morphological changes during long-term culture of hucMSCs by analyzing the cell membrane and nucleus. The ultrastructure of the cell membrane was observed under SEM (<xref rid="f2-mmr-13-06-5207" ref-type="fig">Fig. 2A</xref>). Cells at P4 were spindle-like, plump, stereoscopic and exhibited a large population of uniformly distributed vimineous microvilli. However, at the middle and late phases of the culture (P11 and P17, respectively), hucMSCs became flatter, broader and had numerous large pseudopods, often with multiple secondary bifurcations. Furthermore, the number and length of microvilli was decreased during the late phases, particularly at P17. The current study also used immunofluorescence to observe changes to the cell nuclei (<xref rid="f2-mmr-13-06-5207" ref-type="fig">Fig. 2B</xref>). At P4, the chromatin distribution in the nuclei was homogeneous and the nucleus size was uniform. Compared with P4, the nuclei at P11 and P17 were swollen, and chromatin was localized into a small area termed the senescence-associated heterochromatic foci (SAHF). It was concluded that both the nuclei and the cell membranes of hucMSCs had undergone changes during the long-term <italic>in vitro</italic> culture.</p>
<p>Subsequently, the current study analyzed the growth characteristics of hucMSCs during long-term <italic>in vitro</italic> culture. The proliferation rate of hucMSCs was measured at P4, P11 and P17 by MTT assay (<xref rid="f2-mmr-13-06-5207" ref-type="fig">Fig. 2C</xref>). The hucMSC proliferation rate in the early and middle phases exhibited an S-shaped growth curve, with a minor decrease in proliferation rate in the middle phase compared with the early phase. However, when reaching P17, the hucMSC proliferation rate was significantly decreased compared with the early phase cells (P&lt;0.05). The shape of long-term growth curves differed considerably between passages, with almost a straight line exhibited during the late phase of hucMSC culture.</p>
<p>Additionally, the current study detected SA-&#x003B2;-gal activity at the 3 passages (<xref rid="f2-mmr-13-06-5207" ref-type="fig">Fig. 2D</xref>). The number of senescent cells were increased during the middle and late phase, compared with the early phase (P&lt;0.05; <xref rid="f2-mmr-13-06-5207" ref-type="fig">Fig. 2E</xref>). The results of the current study indicate that hucMSCs undergo replicative senescence during long-term <italic>in vitro</italic> culture.</p>
<p>Considering the functional implications of changes to growth characteristics during multiple passages, the present study analyzed the cell cycle status of hucMSCs. The cell cycle distribution at different passages was determined by FACS analysis. Single-variable histograms of DNA provided data measuring the percentages of cells in the G0/G1, S and G2/M phases of the cell cycle. As presented in <xref rid="f3-mmr-13-06-5207" ref-type="fig">Fig. 3A</xref>, hucMSCs demonstrated a progressive increase in the frequency of cells in G0/G1 phase during long-term <italic>in vitro</italic> culture. Cell cycle analysis of P17 revealed an obvious increase in the number of cells in the G0/G1 phase and a reduction of S-phase cells compared with P4 and P11. The current study did not observe the development of polyploidy in hucMSCs throughout the long-term culture.</p>
<p>CM was collected from P4, P11 and P17 cells, and used as the medium in the lower chamber during a cell migration assay. In the P4 and P11 CM groups, obvious migration of cells was observed, whereas few migrated cells were observed in the P17 CM group. Cell counting demonstrated that the migration of cells in the P17 CM group (19&#x000B1;3.4 cells/100 field) was significantly reduced compared with the P4 and P11 groups (77&#x000B1;3.9 and 62&#x000B1;4.3 cells/field, respectively; P&lt;0.01; <xref rid="f3-mmr-13-06-5207" ref-type="fig">Fig. 3B and C</xref>). The results indicated that senescent hucMSCs may secrete toxic factors into the microenvironment that inhibit hucMSC migration and are harmful to neighboring cells.</p></sec>
<sec>
<title>Long-term culturing of hucMSCs impairs the capacity to differentiate in vitro</title>
<p>In order to observe the differentiation potential of hucMSCs at P4, P11 and P17, the cells were induced to differentiate into adipocytes or osteocytes, as measured by positive staining of Oil Red-O (<xref rid="f4-mmr-13-06-5207" ref-type="fig">Fig. 4A</xref>) and Alizarin Red (<xref rid="f4-mmr-13-06-5207" ref-type="fig">Fig. 4B</xref>), respectively. Based on visual assessment of the extent of Oil Red O-positive lipid inclusions, it was determined that the adipogenic differentiation capacity of hucMSCs was decreased at P11 and P17 compared with at P4. Similarly, the capability of osteogenic differentiation of hucMSCs was decreased at P11 and P17 compared with at P4.</p></sec>
<sec>
<title>Increased levels of intracellular ROS and senescence markers during the long-term culture of hucMSCs</title>
<p>To investigate the levels of intracellular ROS during long-term culture, a fluorescence protocol using H2DCFDA was performed on P4, P11 and P17 hucMSCs. As presented in <xref rid="f5-mmr-13-06-5207" ref-type="fig">Fig. 5A</xref>, the green fluorescence was more intense in P11 and P17 hucMSCs compared with P4 hucMSCs. This suggests that hucMSCs exhibit low intracellular ROS levels during the early phases; but the levels increase in the middle and late phases. To quantify the ROS levels, fluorescence intensity was detected by flow cytometry (<xref rid="f5-mmr-13-06-5207" ref-type="fig">Fig. 5B and C</xref>). The mean fluorescence intensity (MFI) of P11 and P17 were increased compared with at P4. The MFI was increased by 3-fold in P17 hucMSCs and by 2-fold in P11 hucMSCs compared with P4 hucMSCs. Thus, hucMSCs exhibited higher intracellular ROS levels at later passages during the long-term culture (P&lt;0.05; <xref rid="f5-mmr-13-06-5207" ref-type="fig">Fig. 5C</xref>).</p>
<p>To further investigate the association between senescence and oxidative stress, the current study analyzed the mRNA expression of P53, P21 and APE1/Ref-1 in different phases of hucMSC culture. In agreement with a previous study (<xref rid="b19-mmr-13-06-5207" ref-type="bibr">19</xref>), telomeric foci containing multiple DNA damage response factors were assembled in a subset of senescent cells and signaled through ATM to p53, upregulating p21 and causing G1 phase arrest. As demonstrated in <xref rid="f5-mmr-13-06-5207" ref-type="fig">Fig. 5D</xref>, compared with the early passages, P21, P53 and APE1/Ref-1 mRNA levels were significantly increased in the middle and late phases.</p></sec>
<sec>
<title>Establishing a cell model of H<sub>2</sub>O<sub>2</sub>-induced MSC premature senescence</title>
<p>Early passage hucMSCs were treated with H<sub>2</sub>O<sub>2</sub> at different concentrations (0, 200, 400, 600 and 800 <italic>&#x003BC;</italic>M) for 2 h. The stimulus was then removed and cells were further incubated in fresh medium for 48 h. The effect of H<sub>2</sub>O<sub>2</sub> treatment on the cell cycle in P4 hucMSCs was analyzed (<xref rid="f6-mmr-13-06-5207" ref-type="fig">Fig. 6A</xref>). FACS analysis demonstrated that, with increasing concentrations of H<sub>2</sub>O<sub>2</sub>, the number of hucMSCs in the G0/G1 fraction progressively increased, and treatment with 600 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub> significantly promoted cell cycle arrest in the G0/G1 phase (<xref rid="f6-mmr-13-06-5207" ref-type="fig">Fig. 6</xref>; P=0.036).</p>
<p>Following H<sub>2</sub>O<sub>2</sub> treatment, the number of apoptotic cells did not markedly increase, however, the hucMSCs became larger and flatter. Staining of hucMSCs with SA-&#x003B2;-gal indicated that hucMSCs were subjected to senescence following H<sub>2</sub>O<sub>2</sub> stimulation (<xref rid="f6-mmr-13-06-5207" ref-type="fig">Fig. 6B</xref>). In the five H<sub>2</sub>O<sub>2</sub>-treated groups, the proportion of premature senescence cells, as measured by SA-&#x003B2;-gal staining, increased progressively with increasing concentrations of H<sub>2</sub>O<sub>2</sub> (8.17, 13.33, 22.33, 52.17 and 50%; <xref rid="f6-mmr-13-06-5207" ref-type="fig">Fig. 6C</xref>). This indicates that H<sub>2</sub>O<sub>2</sub> promotes senescence of early passage hucMSCs in a concentration-dependent manner. However, the dose of 800 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub> exhibited a slight cytotoxic effect, with viable cells exhibiting poor adherence when washed with PBS. Hence, we propose that a dose of 600 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub> is suitable to establish a model of aging in hucMSCs. Additionally, treatment of P4 hucMSCs with 600 <italic>&#x003BC;</italic>M H<sub>2</sub>O<sub>2</sub> caused them to become larger and flatter, and the cells appeared to be morphologically indistinguishable from replicative senescent cells (P11 or P17).</p>
<p>The expression levels of P53, P21 and APE1/Ref-1 are upregulated in replicative senescence and premature senescence. P53 (P&gt;0.05) and P21 (P&lt;0.05) mRNA expression levels were also increased following H<sub>2</sub>O<sub>2</sub> treatment (<xref rid="f6-mmr-13-06-5207" ref-type="fig">Fig. 6D</xref>). However, at the higher concentrations of H<sub>2</sub>O<sub>2</sub> (600 and 800 <italic>&#x003BC;</italic>M), the expression level of P53 was reduced. The current study interpreted that excessive stimulation of oxidation may decrease the activities of P53 or even inactivate it. Additionally, exposure to H<sub>2</sub>O<sub>2</sub> for 2 h resulted in dose-dependent increased expression levels of APE1/Ref-1 and P21 mRNA in the premature senescence hucMSCs (P&lt;0.05; <xref rid="f6-mmr-13-06-5207" ref-type="fig">Fig. 6D</xref>). This indicates that oxidative stress is important in regulating MSC senescence.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Human MSCs have been isolated from various tissues and are a potential stem cell source for use in regenerative medicine. Typically, stem cell numbers are limited and it is necessary to expand their populations <italic>in vitro</italic> prior to clinical use. In order to examine the characteristics and safety of long-term cultured hucMSCs, the current study evaluated the effects of long-term culture on hucMSC proliferation, phenotype, differentiation, intracellular ROS levels, cell cycle status and senescence-associated gene expression levels. In addition, with the aim to highlight the mechanisms that may cause oxidative stress and promote senescence, the present study established a cell model of H<sub>2</sub>O<sub>2</sub>-induced hucMSC premature senescence to analyze the associations between changes in the microenvi-ronment and the process of aging (<xref rid="b15-mmr-13-06-5207" ref-type="bibr">15</xref>,<xref rid="b25-mmr-13-06-5207" ref-type="bibr">25</xref>).</p>
<p>The present results indicate that hucMSCs undergo replicative senescence during long-term culture <italic>in vitro</italic>, as demonstrated by the altered cell proliferation curve, peculiar cell morphology, cell cycle arrest in G0/G1 and increased SA-&#x003B2;-gal activity, which are known markers of senescence. The current study observed that senescence occurred following a cumulative number of passages, ranging between P4 and P17. Additionally, hucMSCs expanded continuously for &#x02264;30 days and maintained the normal spindle shape under the culture conditions, without demonstrating increased SA-&#x003B2;-gal activity. Consistent with these findings, SAHF were observed in the late phases of hucMSC culture. SAHF is a specific heterochromatic structure accumulating in the nucleus in the form of punctate foci (<xref rid="b26-mmr-13-06-5207" ref-type="bibr">26</xref>,<xref rid="b27-mmr-13-06-5207" ref-type="bibr">27</xref>). By contrast, the chromatin distribution during the early phases of culture was homogeneous. The middle phase may be an interim period of cellular senescence.</p>
<p>Numerous studies have reported the differentiation of MSCs upon replicative senescence (<xref rid="b28-mmr-13-06-5207" ref-type="bibr">28</xref>-<xref rid="b31-mmr-13-06-5207" ref-type="bibr">31</xref>), however, the underlying regulatory mechanism is still controversial. Wagner <italic>et al</italic> (<xref rid="b30-mmr-13-06-5207" ref-type="bibr">30</xref>) demonstrated that the propensity for osteogenic differentiation of MSCs increased and adipogenic differentiation potential decreased during <italic>in vitro</italic> senescence. Kim <italic>et al</italic> (<xref rid="b28-mmr-13-06-5207" ref-type="bibr">28</xref>) reported that the adipogenic and osteogenic differentiation capacity of MSCs were decreased at &gt;30 population doublings.</p>
<p>Oxidative stress is one of the major factors that accelerates cell senescence <italic>in vivo</italic> and <italic>in vitro</italic> (<xref rid="b32-mmr-13-06-5207" ref-type="bibr">32</xref>,<xref rid="b33-mmr-13-06-5207" ref-type="bibr">33</xref>). The current study observed that the generation of ROS in hucMSCs increased during long-term <italic>in vitro</italic> culture. The environment in which cellular senescence evolved is replete with extrinsic hazards and the pace of senescence may be affected by the culture conditions (<xref rid="b10-mmr-13-06-5207" ref-type="bibr">10</xref>,<xref rid="b34-mmr-13-06-5207" ref-type="bibr">34</xref>). H<sub>2</sub>O<sub>2</sub> treatment of early phase hucMSCs provides a useful experimental model to analyze the mechanisms of senescence-associated changes (<xref rid="b35-mmr-13-06-5207" ref-type="bibr">35</xref>&#x02013;<xref rid="b37-mmr-13-06-5207" ref-type="bibr">37</xref>). The results of the current study demonstrate that exogenous stress or oxidative damage cause changes in gene expression levels, contributing to certain changes observed in replicative senescence. It was also observed that the accumulation of intracellular ROS in senescent hucMSCs was accompanied by the upregulation of P21 and P53 mRNA levels. APE1/Ref-1 is able to activate transcription factors associated with the cellular response to various stresses against oxidative DNA damage (<xref rid="b38-mmr-13-06-5207" ref-type="bibr">38</xref>). Similarly, in the present study, the mRNA expression levels of APE1/Ref-1 were elevated in senescent hucMSCs. These results indicate that the P53/P21 pathway may be the primary mediator of hucMSCs aging, and APE1/Ref-1 may be important in the processes of replicative and premature senescence.</p>
<p>In conclusion, the data indicate that long-term <italic>in vitro</italic> culture and extrinsic control, particularly oxidative stress pressure, are crucial in the regulation of stem cell aging. Thus, the quality of MSCs preparations should be carefully controlled prior to clinical application. Further research will be necessary to understand the mechanisms that regulate the replicative senescence of stem cells and how to ensure they remain in the early, normal phase during long-term culture.</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the National Natural Science Foundation of China (grant no. 30840053), the Natural Science Foundation of Jiangsu Province (grant no. BK2008232) and the Foundation of the Jiangsu University for Senior Talented Investigator (grant no. 11JDG0089).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-13-06-5207"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forostyak</surname><given-names>S</given-names></name><name><surname>Jendelova</surname><given-names>P</given-names></name><name><surname>Sykova</surname><given-names>E</given-names></name></person-group><article-title>The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications</article-title><source>Biochimie</source><volume>95</volume><fpage>2257</fpage><lpage>2270</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.biochi.2013.08.004</pub-id><pub-id pub-id-type="pmid">23994163</pub-id></element-citation></ref>
<ref id="b2-mmr-13-06-5207"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name></person-group><article-title>Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis</article-title><source>Stem Cells Dev</source><volume>22</volume><fpage>845</fpage><lpage>854</lpage><year>2013</year><pub-id pub-id-type="doi">10.1089/scd.2012.0395</pub-id><pub-id pub-id-type="pmcid">3585469</pub-id></element-citation></ref>
<ref id="b3-mmr-13-06-5207"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells</article-title><source>Hepatology</source><volume>59</volume><fpage>671</fpage><lpage>682</lpage><year>2014</year><pub-id pub-id-type="doi">10.1002/hep.26670</pub-id></element-citation></ref>
<ref id="b4-mmr-13-06-5207"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodbury</surname><given-names>D</given-names></name><name><surname>Reynolds</surname><given-names>K</given-names></name><name><surname>Black</surname><given-names>IB</given-names></name></person-group><article-title>Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis</article-title><source>J Neurosci Res</source><volume>69</volume><fpage>908</fpage><lpage>917</lpage><year>2002</year><pub-id pub-id-type="doi">10.1002/jnr.10365</pub-id><pub-id pub-id-type="pmid">12205683</pub-id></element-citation></ref>
<ref id="b5-mmr-13-06-5207"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhery</surname><given-names>MS</given-names></name><name><surname>Badowski</surname><given-names>M</given-names></name><name><surname>Muise</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>DT</given-names></name></person-group><article-title>Comparison of human mesenchymal stem cells derived from adipose and cord tissue</article-title><source>Cytotherapy</source><volume>15</volume><fpage>330</fpage><lpage>343</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.jcyt.2012.11.010</pub-id><pub-id pub-id-type="pmid">23318344</pub-id></element-citation></ref>
<ref id="b6-mmr-13-06-5207"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamidi</surname><given-names>MK</given-names></name><name><surname>Nathan</surname><given-names>KG</given-names></name><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Thrichelvam</surname><given-names>ST</given-names></name><name><surname>Mohd Yusof</surname><given-names>NA</given-names></name><name><surname>Fakharuzi</surname><given-names>NA</given-names></name><name><surname>Zakaria</surname><given-names>Z</given-names></name><name><surname>Bhonde</surname><given-names>R</given-names></name><name><surname>Das</surname><given-names>AK</given-names></name><name><surname>Majumdar</surname><given-names>AS</given-names></name></person-group><article-title>Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreser-vation</article-title><source>J Cell Biochem</source><volume>113</volume><fpage>3153</fpage><lpage>3164</lpage><year>2012</year><pub-id pub-id-type="doi">10.1002/jcb.24193</pub-id><pub-id pub-id-type="pmid">22615164</pub-id></element-citation></ref>
<ref id="b7-mmr-13-06-5207"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izadpanah</surname><given-names>R</given-names></name><name><surname>Kaushal</surname><given-names>D</given-names></name><name><surname>Kriedt</surname><given-names>C</given-names></name><name><surname>Tsien</surname><given-names>F</given-names></name><name><surname>Patel</surname><given-names>B</given-names></name><name><surname>Dufour</surname><given-names>J</given-names></name><name><surname>Bunnell</surname><given-names>BA</given-names></name></person-group><article-title>Long-term in vitro expansion alters the biology of adult mesenchymal stem cells</article-title><source>Cancer Res</source><volume>68</volume><fpage>4229</fpage><lpage>4238</lpage><year>2008</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5272</pub-id><pub-id pub-id-type="pmid">18519682</pub-id><pub-id pub-id-type="pmcid">2713721</pub-id></element-citation></ref>
<ref id="b8-mmr-13-06-5207"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>W</given-names></name><name><surname>Ho</surname><given-names>AD</given-names></name><name><surname>Zenke</surname><given-names>M</given-names></name></person-group><article-title>Different facets of aging in human mesenchymal stem cells</article-title><source>Tissue Eng Part B Rev</source><volume>16</volume><fpage>445</fpage><lpage>453</lpage><year>2010</year><pub-id pub-id-type="doi">10.1089/ten.teb.2009.0825</pub-id><pub-id pub-id-type="pmid">20196648</pub-id></element-citation></ref>
<ref id="b9-mmr-13-06-5207"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courtois-Cox</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>SL</given-names></name><name><surname>Cichowski</surname><given-names>K</given-names></name></person-group><article-title>Many roads lead to oncogene-induced senescence</article-title><source>Oncogene</source><volume>27</volume><fpage>2801</fpage><lpage>2809</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/sj.onc.1210950</pub-id><pub-id pub-id-type="pmid">18193093</pub-id></element-citation></ref>
<ref id="b10-mmr-13-06-5207"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakkalakal</surname><given-names>JV</given-names></name><name><surname>Jones</surname><given-names>KM</given-names></name><name><surname>Basson</surname><given-names>MA</given-names></name><name><surname>Brack</surname><given-names>AS</given-names></name></person-group><article-title>The aged niche disrupts muscle stem cell quiescence</article-title><source>Natrue</source><volume>490</volume><fpage>355</fpage><lpage>360</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/nature11438</pub-id></element-citation></ref>
<ref id="b11-mmr-13-06-5207"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandl</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Bechmann</surname><given-names>V</given-names></name><name><surname>Nerlich</surname><given-names>M</given-names></name><name><surname>Angele</surname><given-names>P</given-names></name></person-group><article-title>Oxidative stress induces senescence in human mesenchymal stem cells</article-title><source>Exp Cell Res</source><volume>317</volume><fpage>1541</fpage><lpage>1547</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.yexcr.2011.02.015</pub-id><pub-id pub-id-type="pmid">21376036</pub-id></element-citation></ref>
<ref id="b12-mmr-13-06-5207"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandler</surname><given-names>H</given-names></name><name><surname>Peters</surname><given-names>G</given-names></name></person-group><article-title>Stressing the cell cycle in senescence and aging</article-title><source>Curr Opin Cell Biol</source><volume>25</volume><fpage>765</fpage><lpage>771</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.ceb.2013.07.005</pub-id><pub-id pub-id-type="pmid">23916530</pub-id></element-citation></ref>
<ref id="b13-mmr-13-06-5207"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Hwang</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Shin</surname><given-names>KK</given-names></name><name><surname>Cho</surname><given-names>HH</given-names></name><name><surname>Bae</surname><given-names>YC</given-names></name><name><surname>Jung</surname><given-names>JS</given-names></name></person-group><article-title>miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose</article-title><source>Stem Cells Dev</source><volume>21</volume><fpage>1749</fpage><lpage>1760</lpage><year>2012</year><pub-id pub-id-type="doi">10.1089/scd.2011.0429</pub-id></element-citation></ref>
<ref id="b14-mmr-13-06-5207"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DY</given-names></name><name><surname>Wang</surname><given-names>HJ</given-names></name><name><surname>Tan</surname><given-names>YZ</given-names></name></person-group><article-title>Wnt/&#x003B2;-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway</article-title><source>PLoS One</source><volume>6</volume><fpage>e21397</fpage><year>2011</year><pub-id pub-id-type="doi">10.1371/journal.pone.0021397</pub-id></element-citation></ref>
<ref id="b15-mmr-13-06-5207"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>PJ</given-names></name><name><surname>Yen</surname><given-names>ML</given-names></name><name><surname>Tang</surname><given-names>BC</given-names></name><name><surname>Chen</surname><given-names>CT</given-names></name><name><surname>Yen</surname><given-names>BL</given-names></name></person-group><article-title>H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells</article-title><source>Antioxid Redox Signal</source><volume>18</volume><fpage>1895</fpage><lpage>1905</lpage><year>2013</year><pub-id pub-id-type="doi">10.1089/ars.2012.4692</pub-id><pub-id pub-id-type="pmcid">3624695</pub-id></element-citation></ref>
<ref id="b16-mmr-13-06-5207"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>BR</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Permatasari</surname><given-names>F</given-names></name><name><surname>Gao</surname><given-names>YY</given-names></name><name><surname>Luo</surname><given-names>D</given-names></name></person-group><article-title>Ginsenoside Rg1 protects human fibroblasts against psoralen- and UVA-induced premature senescence through a telomeric mechanism</article-title><source>Arch Dermatol Res</source><volume>304</volume><fpage>223</fpage><lpage>228</lpage><year>2012</year><pub-id pub-id-type="doi">10.1007/s00403-012-1221-9</pub-id><pub-id pub-id-type="pmid">22350182</pub-id></element-citation></ref>
<ref id="b17-mmr-13-06-5207"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>S</given-names></name><name><surname>Sarkar</surname><given-names>B</given-names></name><name><surname>Cholia</surname><given-names>RP</given-names></name><name><surname>Gautam</surname><given-names>N</given-names></name><name><surname>Dhiman</surname><given-names>M</given-names></name><name><surname>Mantha</surname><given-names>AK</given-names></name></person-group><article-title>APE1/Ref-1 as an emerging therapeutic target for various human diseases: Phytochemical modulation of its functions</article-title><source>Exp Mol Med</source><volume>46</volume><fpage>e106</fpage><year>2014</year><pub-id pub-id-type="doi">10.1038/emm.2014.42</pub-id><pub-id pub-id-type="pmid">25033834</pub-id><pub-id pub-id-type="pmcid">4119211</pub-id></element-citation></ref>
<ref id="b18-mmr-13-06-5207"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>Z</given-names></name><name><surname>Choudhury</surname><given-names>AR</given-names></name><name><surname>Rudolph</surname><given-names>KL</given-names></name></person-group><article-title>A dual role of p21 in stem cell aging</article-title><source>Ann N Y Acad Sci</source><volume>100</volume><fpage>333</fpage><lpage>344</lpage><year>2007</year><pub-id pub-id-type="doi">10.1196/annals.1395.036</pub-id></element-citation></ref>
<ref id="b19-mmr-13-06-5207"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbig</surname><given-names>U</given-names></name><name><surname>Jobling</surname><given-names>WA</given-names></name><name><surname>Chen</surname><given-names>BP</given-names></name><name><surname>Chen</surname><given-names>DJ</given-names></name><name><surname>Sedivy</surname><given-names>JM</given-names></name></person-group><article-title>Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a)</article-title><source>MOL CELL</source><volume>14</volume><fpage>501</fpage><lpage>513</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/S1097-2765(04)00256-4</pub-id><pub-id pub-id-type="pmid">15149599</pub-id></element-citation></ref>
<ref id="b20-mmr-13-06-5207"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>M</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name></person-group><article-title>Cellular senescence in cancer and aging</article-title><source>Cell</source><volume>130</volume><fpage>223</fpage><lpage>233</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.cell.2007.07.003</pub-id><pub-id pub-id-type="pmid">17662938</pub-id></element-citation></ref>
<ref id="b21-mmr-13-06-5207"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Tamama</surname><given-names>K</given-names></name></person-group><article-title>Hydrogen gas treatment prolongs replicative lifespan of bone marrow multipotential stromal cells in vitro while preserving differentiation and paracrine potentials</article-title><source>Biochem Biophys Res Commun</source><volume>397</volume><fpage>608</fpage><lpage>613</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.06.009</pub-id><pub-id pub-id-type="pmid">20570654</pub-id></element-citation></ref>
<ref id="b22-mmr-13-06-5207"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ti</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>W</given-names></name></person-group><article-title>Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways</article-title><source>PLoS One</source><volume>8</volume><fpage>e58314</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0058314</pub-id><pub-id pub-id-type="pmid">23516461</pub-id><pub-id pub-id-type="pmcid">3596399</pub-id></element-citation></ref>
<ref id="b23-mmr-13-06-5207"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>TM</given-names></name><name><surname>Tsai</surname><given-names>JL</given-names></name><name><surname>Lin</surname><given-names>SD</given-names></name><name><surname>Lai</surname><given-names>CS</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name></person-group><article-title>Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants</article-title><source>Stem Cells Dev</source><volume>14</volume><fpage>92</fpage><lpage>102</lpage><year>2005</year><pub-id pub-id-type="doi">10.1089/scd.2005.14.92</pub-id><pub-id pub-id-type="pmid">15725748</pub-id></element-citation></ref>
<ref id="b24-mmr-13-06-5207"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharpless</surname><given-names>NE</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name></person-group><article-title>How stem cells age and why this makes us grow old</article-title><source>Nat Rev Mol Cell Biol</source><volume>8</volume><fpage>703</fpage><lpage>713</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/nrm2241</pub-id><pub-id pub-id-type="pmid">17717515</pub-id></element-citation></ref>
<ref id="b25-mmr-13-06-5207"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TT</given-names></name><name><surname>Zeng</surname><given-names>GC</given-names></name><name><surname>Li</surname><given-names>XC</given-names></name><name><surname>Zeng</surname><given-names>HP</given-names></name></person-group><article-title>In vitro studies on the antioxidant and protective effect of 2-substituted -8-hydroxy-quinoline derivatives against H<sub>2</sub>O induced oxidative stress in BMSCs</article-title><source>Chem Biol Drugs Des</source><volume>75</volume><fpage>214</fpage><lpage>222</lpage><year>2010</year><pub-id pub-id-type="doi">10.1111/j.1747-0285.2009.00925.x</pub-id></element-citation></ref>
<ref id="b26-mmr-13-06-5207"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schellenberg</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Schuler</surname><given-names>H</given-names></name><name><surname>Sch&#x000FC;ler</surname><given-names>H</given-names></name><name><surname>Koch</surname><given-names>CM</given-names></name><name><surname>Joussen</surname><given-names>S</given-names></name><name><surname>Denecke</surname><given-names>B</given-names></name><name><surname>Walenda</surname><given-names>G</given-names></name><name><surname>Pallua</surname><given-names>N</given-names></name><name><surname>Suschek</surname><given-names>CV</given-names></name><name><surname>Zenke</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>W</given-names></name></person-group><article-title>Replicative senescence of mesen-chymal stem cells causes DNA-methylation changes which correlate with repressive histone marks</article-title><source>Aging (Albany NY)</source><volume>3</volume><fpage>873</fpage><lpage>888</lpage><year>2011</year><pub-id pub-id-type="doi">10.18632/aging.100391</pub-id></element-citation></ref>
<ref id="b27-mmr-13-06-5207"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Poustovoitov</surname><given-names>MV</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Santos</surname><given-names>HA</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Daganzo</surname><given-names>SM</given-names></name><name><surname>Erzberger</surname><given-names>JP</given-names></name><name><surname>Serebriiskii</surname><given-names>IG</given-names></name><name><surname>Canutescu</surname><given-names>AA</given-names></name><name><surname>Dunbrack</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA</article-title><source>Dev Cell</source><volume>8</volume><fpage>19</fpage><lpage>30</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.devcel.2004.10.019</pub-id></element-citation></ref>
<ref id="b28-mmr-13-06-5207"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>JW</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Choi</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>KD</given-names></name><name><surname>Baek</surname><given-names>DH</given-names></name><name><surname>Seong</surname><given-names>SK</given-names></name><name><surname>Min</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name></person-group><article-title>Biological characterization of long-term cultured human mesenchymal stem cells</article-title><source>Arch Pharm Res</source><volume>32</volume><fpage>117</fpage><lpage>126</lpage><year>2009</year><pub-id pub-id-type="doi">10.1007/s12272-009-1125-1</pub-id><pub-id pub-id-type="pmid">19183884</pub-id></element-citation></ref>
<ref id="b29-mmr-13-06-5207"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>RC</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name></person-group><article-title>Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation</article-title><source>Plos One</source><volume>6</volume><fpage>e20526</fpage><year>2011</year><pub-id pub-id-type="doi">10.1371/journal.pone.0020526</pub-id><pub-id pub-id-type="pmid">21694780</pub-id><pub-id pub-id-type="pmcid">3111432</pub-id></element-citation></ref>
<ref id="b30-mmr-13-06-5207"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>W</given-names></name><name><surname>Horn</surname><given-names>P</given-names></name><name><surname>Castoldi</surname><given-names>M</given-names></name><name><surname>Diehlmann</surname><given-names>A</given-names></name><name><surname>Bork</surname><given-names>S</given-names></name><name><surname>Saffrich</surname><given-names>R</given-names></name><name><surname>Benes</surname><given-names>V</given-names></name><name><surname>Blake</surname><given-names>J</given-names></name><name><surname>Pfister</surname><given-names>S</given-names></name><name><surname>Eckstein</surname><given-names>V</given-names></name><name><surname>Ho</surname><given-names>AD</given-names></name></person-group><article-title>Replicative senescence of mesenchymal stem cells: a continuous and organized process</article-title><source>PLoS One</source><volume>3</volume><fpage>e2213</fpage><year>2008</year><pub-id pub-id-type="doi">10.1371/journal.pone.0002213</pub-id><pub-id pub-id-type="pmid">18493317</pub-id><pub-id pub-id-type="pmcid">2374903</pub-id></element-citation></ref>
<ref id="b31-mmr-13-06-5207"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moerman</surname><given-names>EJ</given-names></name><name><surname>Teng</surname><given-names>K</given-names></name><name><surname>Lipschitz</surname><given-names>DA</given-names></name><name><surname>Lecka-Czernik</surname><given-names>B</given-names></name></person-group><article-title>Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways</article-title><source>Aging Cell</source><volume>3</volume><fpage>379</fpage><lpage>389</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.1474-9728.2004.00127.x</pub-id><pub-id pub-id-type="pmid">15569355</pub-id><pub-id pub-id-type="pmcid">1850101</pub-id></element-citation></ref>
<ref id="b32-mmr-13-06-5207"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>M</given-names></name><name><surname>Rassin</surname><given-names>DK</given-names></name><name><surname>Izumi</surname><given-names>T</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Perez-Polo</surname><given-names>JR</given-names></name></person-group><article-title>APE/Ref-1 responses to oxidative stress in aged rats</article-title><source>J Neurosci Res</source><volume>54</volume><fpage>635</fpage><lpage>638</lpage><year>1998</year><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19981201)54:5&lt;635::AID-JNR8&gt;3.0.CO;2-H</pub-id><pub-id pub-id-type="pmid">9843154</pub-id></element-citation></ref>
<ref id="b33-mmr-13-06-5207"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Halicka</surname><given-names>HD</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Traganos</surname><given-names>F</given-names></name><name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name></person-group><article-title>Constitutive histone H2AX phosphory-lation and ATM activation, the reporters of DNA damage by endogenous oxidants</article-title><source>Cell Cycle</source><volume>5</volume><fpage>1940</fpage><lpage>1945</lpage><year>2006</year><pub-id pub-id-type="doi">10.4161/cc.5.17.3191</pub-id><pub-id pub-id-type="pmid">16940754</pub-id><pub-id pub-id-type="pmcid">3488278</pub-id></element-citation></ref>
<ref id="b34-mmr-13-06-5207"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>W</given-names></name><name><surname>Horn</surname><given-names>P</given-names></name><name><surname>Bork</surname><given-names>S</given-names></name><name><surname>Ho</surname><given-names>AD</given-names></name></person-group><article-title>Aging of hematopoietic stem cells is regulated by the stem cell niche</article-title><source>Exp Gerontol</source><volume>43</volume><fpage>974</fpage><lpage>980</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.exger.2008.04.007</pub-id><pub-id pub-id-type="pmid">18504082</pub-id></element-citation></ref>
<ref id="b35-mmr-13-06-5207"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagi</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Tuan</surname><given-names>RS</given-names></name></person-group><article-title>Polyphenols suppress hydrogen peroxide-induced oxidative stress in human bone-marrow derived mesenchymal stem cells</article-title><source>J Cell Biochem</source><volume>114</volume><fpage>1163</fpage><lpage>1173</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/jcb.24459</pub-id></element-citation></ref>
<ref id="b36-mmr-13-06-5207"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>SK</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Park</surname><given-names>YM</given-names></name><name><surname>Lee</surname><given-names>WT</given-names></name><name><surname>Park</surname><given-names>KA</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name></person-group><article-title>Overexpression of human arginine decarboxylase rescues human mesenchymal stem cells against H O cell survival protein activation</article-title><source>J Korean Med Sci</source><volume>28</volume><fpage>366</fpage><lpage>373</lpage><year>2013</year><pub-id pub-id-type="doi">10.3346/jkms.2013.28.3.366</pub-id><pub-id pub-id-type="pmid">23487582</pub-id><pub-id pub-id-type="pmcid">3594598</pub-id></element-citation></ref>
<ref id="b37-mmr-13-06-5207"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>FW</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>YM</given-names></name><name><surname>Du</surname><given-names>ZX</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>YJ</given-names></name><name><surname>Li</surname><given-names>XG</given-names></name><name><surname>Hao</surname><given-names>AJ</given-names></name></person-group><article-title>Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro</article-title><source>J Cell Biochem</source><volume>114</volume><fpage>2346</fpage><lpage>2355</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/jcb.24582</pub-id><pub-id pub-id-type="pmid">23824714</pub-id></element-citation></ref>
<ref id="b38-mmr-13-06-5207"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>G</given-names></name><name><surname>Gr&#x000F6;sch</surname><given-names>S</given-names></name><name><surname>Tomicic</surname><given-names>M</given-names></name><name><surname>Kaina</surname><given-names>B</given-names></name></person-group><article-title>APE/Ref-1 and the mammalian response to genotoxic stress</article-title><source>Toxicology</source><volume>193</volume><fpage>67</fpage><lpage>78</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0300-483X(03)00290-7</pub-id><pub-id pub-id-type="pmid">14599768</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-mmr-13-06-5207" position="float">
<label>Figure 1</label>
<caption>
<p>Isolation and identification of human umbilical cord mesenchymal stem cells (hucMSCs). (A) Primary cells at passage 0 (magnification, &#x000D7;40). (B) Surface markers identified by fluorescence-activated cell sorting analysis at passage 4. IgG indicates isotypes. HucMSCs are positive for CD29, CD90, CD44 and CD105, but negative for CD34 and HLA-DR. IgG, immunoglobulin G; PE, phycoerythrin; FITC, fluorescein isothiocyanate; CD, cluster of differentiation; HLA-DR, human leukocyte antigen-DR.</p></caption>
<graphic xlink:href="MMR-13-06-5207-g00.jpg"/></fig>
<fig id="f2-mmr-13-06-5207" position="float">
<label>Figure 2</label>
<caption>
<p>Characterization of long-term cultured human umbilical cord mesenchymal stem cells (hucMSCs). (A) Ultrastructure of cell membrane of long-term cultured hucMSCs detected by scanning electron microscopy (magnification, &#x000D7;2,000). (B) Cell nuclei visualized by 4&#x02032;6-diamidino-2-phenylindole staining. Senescence-associated heterochromatic foci formation is present in the nucleus of senescent P17 hucMSCs compared with the nuclei of P4 and P11 (&#x000D7;200 magnification). (C) Growth curve for long-term cultured hucMSCs detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2-H-tetrazolium bromide assay. (D) Representative images (magnification, &#x000D7;100) and (E) quantification of senescent hucMSCs, as detected by SA-&#x003B2;-gal staining. <sup>&#x0002A;</sup>P&lt;0.05 vs. P4. P, passage; SA-&#x003B2;-gal, senescence-associated &#x003B2;-galactosidase.</p></caption>
<graphic xlink:href="MMR-13-06-5207-g01.jpg"/></fig>
<fig id="f3-mmr-13-06-5207" position="float">
<label>Figure 3</label>
<caption>
<p>Effects of long-term <italic>in vitro</italic> culture on the cell cycle and microenvironment of human umbilical cord mesenchymal stem cells (hucMSCs). (A) Cell cycle distribution of hucMSCs at various passages determined by fluorescence-activated cell sorting analysis. (B) HucMSC cell migration assay using hucMSC conditioned media (crystal violet staining; magnification &#x000D7;100). (C) Quantification of migrated cells. <sup>&#x0002A;</sup>P&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. P4. n=4. P, passage.</p></caption>
<graphic xlink:href="MMR-13-06-5207-g02.jpg"/></fig>
<fig id="f4-mmr-13-06-5207" position="float">
<label>Figure 4</label>
<caption>
<p><italic>In vitro</italic> differentiation of human umbilical cord mesenchymal stem cells (hucMSCs). (A) HucMSCs were differentiated into adipocytes for 21 days. Fat accumulation was visualized by Oil Red-O staining (magnification, &#x000D7;200). (B) HucMSCs were differentiated into osteoblasts for 14 days. Osteogenic differentiation was visualized by Alizarin Red staining (magnification, &#x000D7;100). P, passage.</p></caption>
<graphic xlink:href="MMR-13-06-5207-g03.jpg"/></fig>
<fig id="f5-mmr-13-06-5207" position="float">
<label>Figure 5</label>
<caption>
<p>Effects of long-term expansion on intracellular reactive oxygen species (ROS) levels and mRNA expression in human umbilical cord mesenchymal stem cells. (A) Fluorescence microscopy identified more ROS-stained cells in the middle or late phase (P11 or P17) (dihydrodichlorofluorescein diacetate staining). (B and C) Quantification of intracellular ROS levels was performed by fluorescence-activated cell sorting (FACS) analysis of stained cells to obtain mean fluorescence intensity. <sup>&#x0002A;</sup>P&lt;0.05 vs. P4. (D) Reverse transcription-polymerase chain reaction analysis of the expression of P21, P53 and APE1/Ref-1. &#x003B2;-actin was used as an internal control. <sup>&#x0002A;</sup>P&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. P4. P, passage; APE1/Ref-1, apurinic/apyrimidinic endonuclease 1/redox factor-1.</p></caption>
<graphic xlink:href="MMR-13-06-5207-g04.jpg"/></fig>
<fig id="f6-mmr-13-06-5207" position="float">
<label>Figure 6</label>
<caption>
<p>H<sub>2</sub>O<sub>2</sub>-induced cellular premature senescence in human umbilical cord mesenchymal stem cells (hucMSCs). (A) Cell cycle arrest in G1 phase following stimulation with different concentrations H<sub>2</sub>O<sub>2</sub>. (B) Staining of premature senescent hucMSCs with SA-&#x003B2;-gal under different H<sub>2</sub>O<sub>2</sub> concentrations (magnification, &#x000D7;100). (C) Quantification of premature senescence cells. Cells stained blue (SA-&#x003B2;-gal-positive) indicated premature senescence hucMSCs. (D) mRNA expression level of APE1/Ref-1, P53 and P21 in premature senescent hucMSCs. <sup>&#x0002A;</sup>P&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. 0 <italic>&#x003BC;</italic>mol/l treatment. SA-&#x003B2;-gal, senescence-associated &#x003B2;-galactosidase; APE1/Ref-1, apurinic/apyrimidinic endonuclease 1/redox factor-1.</p></caption>
<graphic xlink:href="MMR-13-06-5207-g05.jpg"/></fig></floats-group></article>
